Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Harmony Biosciences Holdings (HRMY) Return on Invested Capital (2022 - 2025)

Historic Return on Invested Capital for Harmony Biosciences Holdings (HRMY) over the last 4 years, with Q3 2025 value amounting to 0.19%.

  • Harmony Biosciences Holdings' Return on Invested Capital changed 0.0% to 0.19% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.19%, marking a year-over-year change of 0.0%. This contributed to the annual value of 0.2% for FY2024, which is 900.0% down from last year.
  • As of Q3 2025, Harmony Biosciences Holdings' Return on Invested Capital stood at 0.19%, which was down 0.0% from 0.2% recorded in Q2 2025.
  • Harmony Biosciences Holdings' Return on Invested Capital's 5-year high stood at 0.61% during Q3 2022, with a 5-year trough of 0.17% in Q1 2025.
  • For the 4-year period, Harmony Biosciences Holdings' Return on Invested Capital averaged around 0.33%, with its median value being 0.27% (2024).
  • Over the last 5 years, Harmony Biosciences Holdings' Return on Invested Capital had its largest YoY gain of 800bps in 2023, and its largest YoY loss of -2900bps in 2023.
  • Over the past 4 years, Harmony Biosciences Holdings' Return on Invested Capital (Quarter) stood at 0.56% in 2022, then crashed by -53bps to 0.26% in 2023, then tumbled by -31bps to 0.18% in 2024, then grew by 3bps to 0.19% in 2025.
  • Its last three reported values are 0.19% in Q3 2025, 0.2% for Q2 2025, and 0.17% during Q1 2025.